Mesa Labs Inc (MLAB) 114.10 $MLAB Cepheid (CPHD) Looks

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2016 at 6:05 PM

Mesa Labs Inc (MLAB) 114.10 $MLAB

Cepheid (CPHD) Looks Good: Stock Adds 8% in Session
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 7:25AM CDT
Cepheid (CPHD) moved big last session, as its shares jumped a little over 8% on the day.
CPHD: 36.76 (+1.43), MLAB: 114.10 (-1.53)

Mesa Labs Reports 16 Percent Increase in First Quarter Revenues
GlobeNewswire - Thu Jul 28, 7:02AM CDT
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company"

today reported a 16 percent increase in revenues for the first quarter ended June 30, 2016.
MLAB: 114.10 (-1.53)

Varian Medical: Claymount Collimators Get FDA Registration
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 7:31AM CDT
Varian Medical Systems, Inc. recently received the U.S. Food and Drug Administration (FDA) registration for its Claymount Optica 20 and Optica 40 collimators.
MASI: 52.93 (-0.04), VAR: 94.84 (+0.10), MLAB: 114.10 (-1.53), NVDQ: 10.92 (+0.26)

AngioDynamics (ANGO) Tops Q4 Earnings, '17 View Positive
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 4:14PM CDT
Shares of AngioDynamics Inc. (ANGO) rallied almost 10%, after the company reported impressive fourth quarter fiscal 2016 results.
ABMD: 119.50 (+1.53), MASI: 52.93 (-0.04), MLAB: 114.10 (-1.53), ANGO: 16.52 (-0.07)

MedTech Tailwinds at a Glance: Which Stocks to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 5:02PM CDT
MedTech Tailwinds at a Glance: Which Stocks to Buy?
ABMD: 119.50 (+1.53), LDRH: 36.98 (-0.02), MDT: 88.06 (+0.43), PAHC: 20.83 (+0.20), MLAB: 114.10 (-1.53), NUVA: 63.29 (+1.09), BSX: 24.43 (+0.15), BABY: 39.18 (-0.15), SNN: 33.18 (-0.11), JNJ: 125.40 (+0.17), DXCM: 92.65 (+0.42), GWPH: 96.11 (+1.79), RMD: 69.85 (+0.97), WOOF: 70.40 (-0.94), ABT: 45.29 (+0.54), VIVO: 19.55 (+0.19), MASI: 52.93 (-0.04), TMO: 159.56 (+0.72), CYH: 12.58 (-0.19), HTWR: 57.96 (+0.02), FEIC: 106.45 (+0.03), ISRG: 693.87 (-1.89), CFMS: 6.92 (-0.05), STE: 71.41 (+0.46), STJ: 83.73 (+0.69), XRAY: 64.23 (+0.19), HOLX: 38.98 (+0.49)

Exactech (EXAC) Scales a 52-Week High on Product Innovation
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 6:56AM CDT
The launch of Acapella One Cervical Spacer System, will boost Exatech's Spine service business to a large extent, fortifying its hold in the space.
ABMD: 119.50 (+1.53), MASI: 52.93 (-0.04), EXAC: 27.20 (+0.17), MLAB: 114.10 (-1.53)

Echo Therapeutics Delisted from Nasdaq, Shares Plummet
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 11:35AM CDT
Shares of Echo Therapeutics Inc. (ECTE) plunged 17.3% to close at $1.48 on Jul 11, after the company announced that it has received a delisting notice from the Nasdaq.
ABMD: 119.50 (+1.53), MASI: 52.93 (-0.04), MLAB: 114.10 (-1.53)

Wright Medical to Sell Large Joints Business to Corin Holdings
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 9:13AM CDT
Wright Medical Group N.V. (WMGI) is set to divest its large joint business to Corin Holdings.
ABMD: 119.50 (+1.53), WMGI: 21.64 (-0.29), BEAT: 19.19 (+0.17), MLAB: 114.10 (-1.53)

Luminex (LMNX) Rallies on FDA Nod for Aries M1 System
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 5:25PM CDT
Luminex Corp. (LMNX) recently announced FDA approval for the Aries M1 system.
ABMD: 119.50 (+1.53), CHEK: 1.30 (+0.04), LMNX: 21.86 (+0.43), MLAB: 114.10 (-1.53)

TrovaGene Inks Partnership with University of Michigan
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 3:31PM CDT
TrovaGene Inc. (TROV) is collaborating with the University of Michigan to conduct a multi-phased research program using Trovera KRAS ctDNA liquid biopsy test.
ABMD: 119.50 (+1.53), MASI: 52.93 (-0.04), TROV: 5.58 (-0.05), MLAB: 114.10 (-1.53)

Mesa Labs Declares Quarterly Dividend
GlobeNewswire - Wed Jul 06, 10:53AM CDT
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company"

today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2016, to shareholders of record at the close of business on August 31, 2016.
MLAB: 114.10 (-1.53)

Thermo Fisher Grows Globally; Affimetrix Synergy on Track
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:17AM CDT
On Jun 20, 2016, we issued an updated research report on Thermo Fisher Scientific Inc. (TMO).
MASI: 52.93 (-0.04), TMO: 159.56 (+0.72), CRY: 14.32 (-0.25), MLAB: 114.10 (-1.53)

IRadimed (IRMD) Raised to Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:18AM CDT
On Jun 17, Zacks Investment Research raised IRadimed Corp. (IRMD) to a Zacks Rank #1 (Strong Buy).
IRMD: 19.08 (-0.28), MASI: 52.93 (-0.04), CRY: 14.32 (-0.25), MLAB: 114.10 (-1.53)

Can The Uptrend Continue for with Mesa Laboratories (MLAB)?
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 8:51AM CDT
Investors certainly have to be happy with Mesa Laboratories Inc. (MLAB) and its short term performance
MLAB: 114.10 (-1.53)

Zacks Investment Ideas feature highlights: Apple Hospitality REIT, Coresite Realty, Brookfield CDA, Mesa Labs and Cryolife
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 8:30AM CDT
Zacks Investment Ideas feature highlights: Apple Hospitality REIT, Coresite Realty, Brookfield CDA, Mesa Labs and Cryolife
APLE: 20.47 (+0.10), COR: 83.43 (+0.90), CRY: 14.32 (-0.25), MLAB: 114.10 (-1.53), BOXC: 22.09 (unch)

CryoLife (CRY) Raised to Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 6:05AM CDT
On Jun 11, Zacks Investment Research raised CryoLife Inc. (CRY) to a Zacks Rank #1 (Strong Buy).
IRMD: 19.08 (-0.28), MASI: 52.93 (-0.04), CRY: 14.32 (-0.25), MLAB: 114.10 (-1.53)

Five Recent Strong Buys In Two Industries
Brian Bolan - Zacks Investment Research - Fri Jun 10, 8:32AM CDT
Five Recent Strong Buys In Two Industries
APLE: 20.47 (+0.10), COR: 83.43 (+0.90), CRY: 14.32 (-0.25), MLAB: 114.10 (-1.53), BOXC: 22.09 (unch)

New Strong Buy Stocks for June 9th
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 6:50AM CDT
New Strong Buy Stocks for June 9th
UNFI: 50.02 (+0.04), APLE: 20.47 (+0.10), PLAY: 44.29 (-0.21), MLAB: 114.10 (-1.53), CORE: 48.75 (-0.21)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cure Blindness Project's 770K Screenings for World Sight Day

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

Purina Institute Highlights Nutritional Science at WSAVA 2026

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

TA Services Strengthens U.S.-Mexico Freight Operations

TA Services Moves Boldly Across Borders If ever there was a time to play the logistics chessboard like a champ, it's now, and TA Services just slammed the board with a solid move. They've grabbed Carmen Pacheco Transportation and Interload Forwarding, two family-run operations with some real muscle in North American logistics. This isn't a small-time maneuver; they've...

Bob Evans' Protein Mac & Cheese: Practical Power Play

Has anyone else noticed just how fast the world spins when it comes to consumer trends these days? Bob Evans is hopping right on the protein bandwagon with its latest launch, a microwave-ready Protein Macaroni & Cheese that packs 18 grams of protein per serving. You gotta hand it to them for seizing opportunity when they see it. This one's not just about tossing a new...

Community Banks Missing $106B Lending Opportunity?

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Navigating Holiday Sweets: Healthy Balancing Acts

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...

Skandia's Soundproofing Kit Expands to Brazil's Skies

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

Epic Political Thriller Explores Humanity's Future

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...

Pushing for National Liver Cancer Awareness in 2026

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...